Relationship between serum 25-hydroxyvitamin D and inflammatory cytokines in Nigerian children with asthma

Bankole Peter Kuti1,2, Demilade K Kuti1

  • 1Department of Paediatrics, Wesley Guild Hospital, Ilesa, Nigeria.

Insights

Nigerian children with asthma had lower serum vitamin D (25-hydroxyvitamin D) and inflammatory cytokines compared to healthy controls. Serum vitamin D showed a complex, non-linear relationship with T-helper cell type 1 and type 2 cytokines.

Area of Science:

  • Pediatric Allergy and Immunology
  • Nutritional Immunology
  • Respiratory Medicine

Background:

  • Childhood asthma pathogenesis involves complex inflammatory cytokine networks.
  • The role of serum vitamin D (25-hydroxyvitamin D), an immunomodulator, in childhood asthma is not well understood.
  • Investigating vitamin D's influence on T-helper cell cytokines in asthmatic Nigerian children is crucial.

Purpose of the Study:

  • To determine the relationship between serum 25-hydroxyvitamin D (25-OHD) and various T-helper cell type 1 (Th1) and type 2 (Th2) cytokines in Nigerian children with asthma.
  • To compare vitamin D levels and cytokine profiles between asthmatic children and non-asthmatic controls.

Main Methods:

  • A case-control study involving 180 Nigerian children (aged 2-15 years), with 90 diagnosed with asthma and 90 controls.
  • Serum 25-hydroxyvitamin D (25-OHD) and multiple interleukins (ILs) were measured using chromatography.
  • Statistical analyses were performed to determine associations between vitamin D status and cytokine levels.

Main Results:

  • Children with asthma exhibited significantly lower mean serum vitamin D levels (38.8 ng/ml) compared to controls (45.5 ng/ml).
  • A higher proportion of asthmatic children had suboptimal serum vitamin D levels (26.0% vs. 8.8%).
  • Serum vitamin D showed significant positive correlations with Th1 cytokines (IL-2, IL-8) and Th2 cytokines (IL-3, IL-4, IL-5, IL-9), but a negative correlation with IL-13. Cytokine levels were highest in the normal vitamin D state.

Conclusions:

  • Serum vitamin D and certain cytokines were found to be lower in Nigerian children with asthma compared to controls.
  • Vitamin D status did not correlate with asthma severity or control in this cohort.
  • Serum 25-OHD appears to have a non-linear relationship with Th1 and Th2 cytokines in Nigerian children with asthma.

Related Concept Videos

Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.1K
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.0K
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.0K
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
3.2K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
1.7K
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.3K